SHIFTY MEDICINE: Kayexalate is a potentially harmful therapy to treat hyperkalemia

Kayexalate is a potentially harmful therapy to treat hyperkalemia, it has a slow onset action (if at all) and doubtful efficacy. It also carries risk of life threatening gastrointestinal complications. There is NO CONVINCING EVIDENCE that Kayexalate increases fecal potassium losses.

EMKF

Emergency Medicine Kenya Foundation (EMKF) is a not-for-profit (NGO) public benefit organisation registered in Kenya